Dr. Ben Goertzel
Chief Executive and Chief Science Officer.

Ben has been involved in AI research and application development since the late 1980’s. He holds a PhD in mathematics from Temple University, and over the period 1989-1997 he held several university faculty positions in mathematics, computer science, and psychology, in the US, New Zealand and Australia.  

He is author of numerous research papers and journalistic articles, a biography of Linus Pauling, and five scholarly books dealing with topics in the cognitive sciences, including Chaotic Logic (Plenum Press, 1994), and Creating Internet Intelligence (Plenum Press, 2001).  Two technical books describing many of the concepts underpinning the Biomind AI Engine, coauthored with Cassio Pennachin, will be forthcoming in late 2005.

After publishing several papers on systems biology in the 1990's, in 2000 Dr. Goertzel began serious research into novel AI-driven methods of extracting patterns from genomic and proteomic data, with an initial emphasis on microarray data.  Thus Biomind was born.

Cassio Pennachin
Chief Technology Officer.

Cassio has been leading software development projects since the mid-1990's, in artificial intelligence, bioinformatics, operations research and other areas.  Prior to the founding of Biomind, he led a team developing mass spectrometry data analysis software for Proteometrics.  From 1998-2001 Cassio was the former VP of R&D at Webmind Inc. , leading several projects in AI, data mining and information retrieval. 

Robert Bradbury

Founder and leader of Aieveos Corporation and Aieveos Sciences Group, Robert has been researching biological and nanotechnological approaches to life extension since the early 1990's.

Dr. Aubrey de Grey

Perhaps the most innovative contemporary researcher in the field of biogerontology, Dr. de Grey currently carries out his research at the Department of Genetics of the University of Cambridge.  For information on his work, see his Strategies for Engineering Negligible Senescence website.

W.  Davis Parker Jr., MD

Professor of Neurology and Pediatrics and Head of the Division of Pediatric Neurology at the University of Virginia Health System, Dr. Parker is a foremost authority on mitochondrial genetics and neurodegenerative disease.  

Dr. Richard Scheuermann

Dr. Scheuermann is the Director of the Division of Translational Pathology at Southwestern Medical Center.   His research is unusually diverse, spannning areas such as signal transduction, lymphocyte homeostasis, cancer biology, immunology, bioinformatics, database development, computational biology, molecular diagnostics, and biodefense.

Rafal Smigrodzki, MD, PhD

A neurologist with expertise in mitochondrial function, Dr. Smigrodzki is currently working with Gencia Corporation in Charlottesville VA, researching protofection and other approaches for manipulating the mitochondrial genome.